Kobayashi Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 3.24% vs -10.63% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -36.11% vs 66.29% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33,665.00",
          "val2": "32,607.00",
          "chgp": "3.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,612.00",
          "val2": "4,722.00",
          "chgp": "-23.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.00",
          "val2": "4.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-415.00",
          "val2": "-781.00",
          "chgp": "46.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,037.00",
          "val2": "1,623.00",
          "chgp": "-36.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.20%",
          "val2": "77.80%",
          "chgp": "-3.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.09% vs -4.53% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -63.66% vs -50.48% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "165,742.00",
          "val2": "165,600.00",
          "chgp": "0.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23,590.00",
          "val2": "32,883.00",
          "chgp": "-28.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "28.00",
          "val2": "28.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-18,411.00",
          "val2": "-13,687.00",
          "chgp": "-34.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,660.00",
          "val2": "10,071.00",
          "chgp": "-63.66%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "89.60%",
          "val2": "150.10%",
          "chgp": "-6.05%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

33,665.00

32,607.00

3.24%

Operating Profit (PBDIT) excl Other Income

3,612.00

4,722.00

-23.51%

Interest

4.00

4.00

Exceptional Items

-415.00

-781.00

46.86%

Consolidate Net Profit

1,037.00

1,623.00

-36.11%

Operating Profit Margin (Excl OI)

40.20%

77.80%

-3.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 3.24% vs -10.63% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -36.11% vs 66.29% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

165,742.00

165,600.00

0.09%

Operating Profit (PBDIT) excl Other Income

23,590.00

32,883.00

-28.26%

Interest

28.00

28.00

Exceptional Items

-18,411.00

-13,687.00

-34.51%

Consolidate Net Profit

3,660.00

10,071.00

-63.66%

Operating Profit Margin (Excl OI)

89.60%

150.10%

-6.05%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.09% vs -4.53% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -63.66% vs -50.48% in Dec 2024

All Annual Results